Anoop Kishore

718 total citations
52 papers, 494 citations indexed

About

Anoop Kishore is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anoop Kishore has authored 52 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Anoop Kishore's work include Cancer-related cognitive impairment studies (8 papers), Computational Drug Discovery Methods (5 papers) and Phytochemicals and Antioxidant Activities (4 papers). Anoop Kishore is often cited by papers focused on Cancer-related cognitive impairment studies (8 papers), Computational Drug Discovery Methods (5 papers) and Phytochemicals and Antioxidant Activities (4 papers). Anoop Kishore collaborates with scholars based in India, Saudi Arabia and United Kingdom. Anoop Kishore's co-authors include Krishnadas Nandakumar, Pawan G. Nayak, Runali Sankhe, Rekha R. Shenoy, K. Sreedhara Ranganath Pai, C. Mallikarjuna Rao, Sri Pragnya Cheruku, Nitesh Kumar, Madhavan Nampoothiri and Gollapalle Lakshminarayanashastry Viswanatha and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Drug Discovery Today.

In The Last Decade

Anoop Kishore

45 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anoop Kishore India 13 154 82 53 52 50 52 494
Esther T. Menze Egypt 17 199 1.3× 91 1.1× 60 1.1× 84 1.6× 79 1.6× 32 659
Mina Y. George Egypt 14 161 1.0× 97 1.2× 47 0.9× 54 1.0× 38 0.8× 35 498
Xin-Rong Xu China 13 320 2.1× 39 0.5× 39 0.7× 49 0.9× 48 1.0× 31 694
Reem N. El‐Naga Egypt 18 251 1.6× 60 0.7× 39 0.7× 54 1.0× 48 1.0× 32 792
Claudio Bardelli Italy 16 302 2.0× 80 1.0× 132 2.5× 60 1.2× 39 0.8× 32 758
Mohamed K. El-Kherbetawy Egypt 16 196 1.3× 24 0.3× 62 1.2× 41 0.8× 47 0.9× 36 609
Li‐Jen Chen Taiwan 15 256 1.7× 61 0.7× 75 1.4× 67 1.3× 29 0.6× 32 548
Caner Günaydın Türkiye 11 168 1.1× 51 0.6× 46 0.9× 99 1.9× 32 0.6× 26 519
Xiaoli Hou China 12 225 1.5× 31 0.4× 63 1.2× 37 0.7× 29 0.6× 31 516

Countries citing papers authored by Anoop Kishore

Since Specialization
Citations

This map shows the geographic impact of Anoop Kishore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anoop Kishore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anoop Kishore more than expected).

Fields of papers citing papers by Anoop Kishore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anoop Kishore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anoop Kishore. The network helps show where Anoop Kishore may publish in the future.

Co-authorship network of co-authors of Anoop Kishore

This figure shows the co-authorship network connecting the top 25 collaborators of Anoop Kishore. A scholar is included among the top collaborators of Anoop Kishore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anoop Kishore. Anoop Kishore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kishore, Anoop, et al.. (2025). Structure–activity relationships of KRAS-G12D inhibitors for pancreatic cancer. Drug Discovery Today. 30(7). 104396–104396.
3.
Viswanatha, Gollapalle Lakshminarayanashastry, et al.. (2024). Docosahexaenoic Acid and Pregnancy: A Systematic Review and Meta-Analysis of the Association with Improved Maternal and Fetal Health. Nutrition Research. 128. 82–93. 2 indexed citations
4.
Kishore, Anoop, et al.. (2024). Oral Cancer Detection Using Convolutional Neural Networks. 1–5. 1 indexed citations
5.
Sankhe, Runali, et al.. (2024). Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide‐Induced Sickness‐Like Behaviour in Mice. Advances in Pharmacological and Pharmaceutical Sciences. 2024(1). 8599268–8599268. 1 indexed citations
6.
Sankhe, Runali, et al.. (2024). An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma. Journal of Biomolecular Structure and Dynamics. 43(17). 9776–9789. 4 indexed citations
7.
Sankhe, Runali, et al.. (2024). New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation. Journal of Neuroimmune Pharmacology. 19(1). 7–7. 53 indexed citations
8.
Viswanatha, Gollapalle Lakshminarayanashastry, Pawan G. Nayak, Abhinav Kanwal, et al.. (2023). Mechanisms behind the pharmacological application of biochanin-A: a review. F1000Research. 12. 107–107.
9.
Kishore, Anoop, et al.. (2023). Online Hand Gesture Recognition and Classification for Deaf and Dumb. 6. 229–234. 1 indexed citations
10.
Viswanatha, Gollapalle Lakshminarayanashastry, Pawan G. Nayak, Abhinav Kanwal, et al.. (2023). Mechanisms behind the pharmacological application of biochanin-A: a review. F1000Research. 12. 107–107.
11.
Keni, Raghuvir, Pawan G. Nayak, Nitesh Kumar, et al.. (2023). Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability. 3 Biotech. 13(11). 377–377. 2 indexed citations
12.
Gourishetti, Karthik, Pawan G. Nayak, C. Mallikarjuna Rao, et al.. (2022). Amelioration of Doxorubicin-Induced Cognitive Impairment by Quercetin in a Rat Model of Breast Cancer. Revista Brasileira de Farmacognosia. 33(1). 153–163. 4 indexed citations
13.
Mathew, Anna, et al.. (2021). ABO phenotype and SARS-CoV-2 infection: Is there any correlation?. Infection Genetics and Evolution. 90. 104751–104751. 3 indexed citations
14.
Sankhe, Runali, K. Sreedhara Ranganath Pai, & Anoop Kishore. (2020). Tumour suppression through modulation of neprilysin signaling: A comprehensive review. European Journal of Pharmacology. 891. 173727–173727. 18 indexed citations
15.
Sankhe, Runali, Ekta Rathi, Suman Manandhar, et al.. (2020). Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study. Journal of Molecular Structure. 1224. 129073–129073. 27 indexed citations
16.
Kishore, Anoop, et al.. (2018). Role of choline-docosahexaenoic acid and trigonella foenum graecum seed extract on ovariectomy induced dyslipidemia and oxidative stress in rat model. SHILAP Revista de lepidopterología. 7(1). 1–7. 3 indexed citations
17.
Cheruku, Sri Pragnya, Anoop Kishore, Pawan G. Nayak, et al.. (2017). Insulin Protects against Brain Oxidative Stress with an Apparent Effect on Episodic Memory in Doxorubicin-Induced Cognitive Dysfunction in Wistar Rats. Journal of Environmental Pathology Toxicology and Oncology. 36(2). 121–130. 11 indexed citations
18.
Mudgal, Jayesh, et al.. (2017). Heterocyclic homoprostanoid derivative attenuates monoarthritis in rats: An in vitro and in vivo preclinical paradigm. European Journal of Pharmaceutical Sciences. 111. 320–329. 1 indexed citations
19.
Nandakumar, Krishnadas, et al.. (2016). Sambar, an Indian dish prevents the development of dimethyl hydrazine-induced colon cancer: A preclinical study. Pharmacognosy Magazine. 12(47). 441–441. 14 indexed citations
20.
Kishore, Anoop, Gopalan Kutty Nampurath, Bhagath Kumar Potu, et al.. (2008). Antidiabetic effect through islet cell protection in streptozotocin diabetes: A preliminary assessment of two thiazolidin-4-ones in Swiss albino mice. Chemico-Biological Interactions. 177(3). 242–246. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026